Neuronetics STIM 深 沪
等待开盘 06-30 09:30:00 美东时间
1.36
+0.020
+1.49%
华盛通- 最 高1.56
- 今 开1.34
- 成交量 155.78万股
- 最 低 1.33
- 昨 收 1.34
- 总市值 9.46万
- 52周最高 4.8495
- 市盈率 静 --
- 换手率 2238.63%
- 52周最低 0.80
- 委 比 -70.14%
- 总股本 6.96万
- 历史最高 39.39
- 量 比 0.85
- 振 幅 17.16%
- 历史最低 0.52
- 每 手 1
- 风险率 0.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Neuronetics Promotes Cory Anderson to Lead Greenbrook Unit
An announcement from Neuronetics ( ($STIM) ) is now available. On June 16, 2026...
06-24 06:01
Neuronetics, Inc.2026年Q1营收3450万美元 亏损收窄
经济观察网 Neuronetics, Inc.公布2026年第一季度业绩，营收同比增长，亏损有所收窄，同时披露成本优化计划与全年业绩指引。 业绩经营情况： 公司...
05-28 23:08
Neuronetics shifts interim finance officer Brown to $26,000 monthly consulting fee
Neuronetics shifts interim finance officer Brown to $26,000 monthly consulting fee Neuronetics revised the consulting compensation for interim principal financial and accounting officer Francis X. Brown III to USD 26,000 per month, replacing a fixed hourly rate. The amended and restated consulting a
05-22 19:33
Neuronetics Collaborates With ANT Neuro To Expand NeuroStar Advanced Therapy System
Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of
05-14 20:42
Neuronetics shares are trading higher after the company reported better-than-expected Q1 financial results and reaffirmed its FY2026 sales guidance.
Neuronetics shares are trading higher after the company reported better-than-ex...
05-05 23:26
Full Transcript: Neuronetics Q1 2026 Earnings Call
Neuronetics (NASDAQ:STIM) held its first-quarter earnings conference call on Tu...
05-05 21:25
Neuronetics Affirms FY2026 Sales Guidance of $160.000M-$166.000M vs $162.467M Est
Business OutlookFor the second quarter of 2026, the Company expects total revenue growth in the mid-single digits.For the full year 2026, Neuronetics continues to expect:Total revenue between $160 million and $166
05-05 19:54
Neuronetics Q1 EPS $(0.16) Beats $(0.17) Estimate, Sales $34.454M Beat $34.183M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 23.81 percent increase over losses of $(0.21) per share from the
05-05 19:53
BRIEF-Neuronetics Q1 Gross Margin 46.9%
BRIEF-Neuronetics Q1 Gross Margin 46.9% May 05 (Reuters) - Neuronetics Q1 operating expenses USD 25.1 million. Q1 EPS USD -0.16
05-05 19:50
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
